Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1947 10
1949 1
1950 4
1951 1
1952 2
1953 2
1955 1
1956 3
1957 1
1958 2
1959 2
1960 1
1961 2
1962 2
1963 4
1964 3
1965 2
1966 4
1967 7
1968 8
1969 6
1970 5
1971 8
1972 5
1973 3
1974 6
1975 7
1976 11
1977 13
1978 10
1979 19
1980 11
1981 24
1982 21
1983 24
1984 22
1985 31
1986 24
1987 38
1988 57
1989 43
1990 52
1991 76
1992 76
1993 83
1994 105
1995 71
1996 99
1997 75
1998 76
1999 89
2000 107
2001 91
2002 120
2003 99
2004 113
2005 146
2006 165
2007 161
2008 170
2009 210
2010 219
2011 272
2012 310
2013 291
2014 286
2015 289
2016 316
2017 356
2018 348
2019 335
2020 410
2021 496
2022 422
2023 438
2024 412
2025 301

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,350 results

Results by year

Filters applied: . Clear all
Page 1
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
O'Donoghue ML, Rosenson RS, Gencer B, López JAG, Lepor NE, Baum SJ, Stout E, Gaudet D, Knusel B, Kuder JF, Ran X, Murphy SA, Wang H, Wu Y, Kassahun H, Sabatine MS; OCEAN(a)-DOSE Trial Investigators. O'Donoghue ML, et al. Among authors: lopez jag. N Engl J Med. 2022 Nov 17;387(20):1855-1864. doi: 10.1056/NEJMoa2211023. Epub 2022 Nov 6. N Engl J Med. 2022. PMID: 36342163 Free article. Clinical Trial.
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.
André P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T, Bléry M, Bonnafous C, Gauthier L, Morel A, Rossi B, Remark R, Breso V, Bonnet E, Habif G, Guia S, Lalanne AI, Hoffmann C, Lantz O, Fayette J, Boyer-Chammard A, Zerbib R, Dodion P, Ghadially H, Jure-Kunkel M, Morel Y, Herbst R, Narni-Mancinelli E, Cohen RB, Vivier E. André P, et al. Among authors: lopez j. Cell. 2018 Dec 13;175(7):1731-1743.e13. doi: 10.1016/j.cell.2018.10.014. Epub 2018 Nov 29. Cell. 2018. PMID: 30503213 Free PMC article. Review.
Type 2 immunity in allergic diseases.
Ogulur I, Mitamura Y, Yazici D, Pat Y, Ardicli S, Li M, D'Avino P, Beha C, Babayev H, Zhao B, Zeyneloglu C, Giannelli Viscardi O, Ardicli O, Kiykim A, Garcia-Sanchez A, Lopez JF, Shi LL, Yang M, Schneider SR, Skolnick S, Dhir R, Radzikowska U, Kulkarni AJ, Imam MB, Veen WV, Sokolowska M, Martin-Fontecha M, Palomares O, Nadeau KC, Akdis M, Akdis CA. Ogulur I, et al. Among authors: lopez jf. Cell Mol Immunol. 2025 Mar;22(3):211-242. doi: 10.1038/s41423-025-01261-2. Epub 2025 Feb 17. Cell Mol Immunol. 2025. PMID: 39962262 Free PMC article. Review.
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer.
García-Vílchez R, Añazco-Guenkova AM, Dietmann S, López J, Morón-Calvente V, D'Ambrosi S, Nombela P, Zamacola K, Mendizabal I, García-Longarte S, Zabala-Letona A, Astobiza I, Fernández S, Paniagua A, Miguel-López B, Marchand V, Alonso-López D, Merkel A, García-Tuñón I, Ugalde-Olano A, Loizaga-Iriarte A, Lacasa-Viscasillas I, Unda M, Azkargorta M, Elortza F, Bárcena L, Gonzalez-Lopez M, Aransay AM, Di Domenico T, Sánchez-Martín MA, De Las Rivas J, Guil S, Motorin Y, Helm M, Pandolfi PP, Carracedo A, Blanco S. García-Vílchez R, et al. Among authors: lopez j. Mol Cancer. 2023 Jul 29;22(1):119. doi: 10.1186/s12943-023-01809-8. Mol Cancer. 2023. PMID: 37516825 Free PMC article.
Development of PainFace software to simplify, standardize, and scale up mouse grimace analyses.
McCoy ES, Park SK, Patel RP, Ryan DF, Mullen ZJ, Nesbitt JJ, Lopez JE, Taylor-Blake B, Vanden KA, Krantz JL, Hu W, Garris RL, Snyder MG, Lima LV, Sotocinal SG, Austin JS, Kashlan AD, Shah S, Trocinski AK, Pudipeddi SS, Major RM, Bazick HO, Klein MR, Mogil JS, Wu G, Zylka MJ. McCoy ES, et al. Among authors: lopez je. Pain. 2024 Aug 1;165(8):1793-1805. doi: 10.1097/j.pain.0000000000003187. Epub 2024 Feb 13. Pain. 2024. PMID: 39024163 Free PMC article.
Remodeling p38 signaling in muscle controls locomotor activity via IL-15.
Folgueira C, Herrera-Melle L, López JA, Galvan-Alvarez V, Martin-Rincon M, Cuartero MI, García-Culebras A, Dumesic PA, Rodríguez E, Leiva-Vega L, León M, Porteiro B, Iglesias C, Torres JL, Hernández-Cosido L, Bonacasa C, Marcos M, Moro MÁ, Vázquez J, Calbet JAL, Spiegelman BM, Mora A, Sabio G. Folgueira C, et al. Among authors: lopez ja. Sci Adv. 2024 Aug 16;10(33):eadn5993. doi: 10.1126/sciadv.adn5993. Epub 2024 Aug 14. Sci Adv. 2024. PMID: 39141732 Free PMC article.
Imidazole propionate is a driver and therapeutic target in atherosclerosis.
Mastrangelo A, Robles-Vera I, Mañanes D, Galán M, Femenía-Muiña M, Redondo-Urzainqui A, Barrero-Rodríguez R, Papaioannou E, Amores-Iniesta J, Devesa A, Lobo-González M, Carreras A, Beck KR, Ivarsson S, Gummesson A, Georgiopoulos G, Rodrigo-Tapias M, Martínez-Cano S, Fernández-López I, Nuñez V, Ferrarini A, Inohara N, Stamatelopoulos K, Benguría A, Cibrian D, Sánchez-Madrid F, Alonso-Herranz V, Dopazo A, Barbas C, Vázquez J, López JA, González-Martín A, Nuñez G, Stellos K, Bergström G, Bäckhed F, Fuster V, Ibañez B, Sancho D. Mastrangelo A, et al. Among authors: lopez ja. Nature. 2025 Sep;645(8079):254-261. doi: 10.1038/s41586-025-09263-w. Epub 2025 Jul 16. Nature. 2025. PMID: 40670786 Free PMC article.
7,350 results